| Cancer types mentioned | Food it is found in | |
| Breast, Colorectal, Gastric, Leukemia, Liver, Lung, Pancreatic, Prostate, Multiple Myeloma, Esophageal/Throat, Ovarian, Endometrial, Non-Hodgkin Lymphoma | Turmeric (Curcuma longa) |
Curcumin
-
Cancer Types: Head and neck carcinomas, breast, colon, prostate, gastric, leukemia, lymphoma, and melanoma.
-
Food Occurrences: The primary active component of Turmeric (Curcuma longa), a staple spice in conventional foods.
-
Curcumin is one of the most widely researched natural compounds in modern science, working on numerous molecular targets like tumor suppressor genes, apoptotic proteins (Bax/Bcl-2), and pro-inflammatory pathways such as NF-κB.
-
While it naturally has low bioavailability, its strong safety record and multi-targeted effects make it a key focus in “supportive food” research and integrative oncology. Studies show lower rates of certain cancers in areas with high turmeric intake, like India. New delivery methods, including liposomal and micellar formulations, help boost its presence in tumor tissues, greatly improving its ability to trigger apoptosis and block angiogenesis.
-
Remainder of Report & Sources:
-
Mechanisms: Downregulation of MMP-9, inhibition of P-gp and BCRP transporters, and induction of ROS.
-
Combinations: Synergistic with resveratrol for head and neck cancers, and with emodin for breast cancer.
-
Primary Source: Cui et al., Chinese Medicine, 2025
-
Additional Source: PMC – Synergistic Combinations
-
-
Primary Food Sources: Turmeric (Curcuma longa).
-
Molecular Targets: A “master regulator” that inhibits NF-κB, STAT3, and COX-2. It triggers the p53 tumor suppressor and blocks the PI3K/Akt/mTOR survival pathway.
-
Bioavailability: Notorious for poor absorption. Efficacy is significantly boosted when taken with Piperine (black pepper extract) or formulated as a phytosome.
-
Cross-Links:
-
Emodin & Resveratrol: Form part of the “TriCurin” formulation, which shows massive synergy in eliminating HPV-positive cervical cancer cells.
-
Ursolic Acid: Synergizes to block glutamine uptake in Prostate Cancer cells.
-
Silibinin: Combined treatment is effective against Colon Cancer proliferation.
-